Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

DiABZI STING agonist-1

DiABZI STING agonist-1 is a tautomerism of diABZI STING agonist-1 tautomerism (HY-112921) . diABZI STING agonist-1 is a selective stimulator of interferon genes (STING) receptor agonist, with EC50s of 130, 186 nM for human and mouse, respectively[1].

Product Specifications

CAS Number

[2138299-33-7]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

STING

Type

Reference compound

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/diABZI_STING_agonist-1_Tautomerism.html

Concentration

10mM

Purity

99.86

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(N)C1=CC(N=C(NC(C2=CC(C)=NN2CC)=O)N3C/C=C/CN4C(NC(C5=CC(C)=NN5CC)=O)=NC6=C4C(OCCCN7CCOCC7)=CC(C(N)=O)=C6)=C3C(OC)=C1

Molecular Formula

C42H51N13O7

Molecular Weight

849.94

Precautions

H302, H315, H319, H335

References & Citations

[1]Ramanjulu JM, et al. Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature. 2018 Nov 7.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture and light)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Citation 01

Adv Sci (Weinh) . 2024 Nov 19:e2407222.|Biomed Pharmacother. 2024 Feb:171:116007.|Cancer Lett. 2024 May 1:589:216836.|Cell Death Differ. 2024 Jan;31 (1) :78-89.|Cell Death Differ. 2025 Jun;32 (6) :1167-1179.|Cell Rep. 2025 Nov 18;44 (12) :116581.|Chin Herb Med. 2024 Apr 30;16 (3) :422-434.|Chin Herb Med. 2025 Jan 7.|Chin Med. 2024 Aug 15;19 (1) :107.|FASEB J. 2025 Apr 15;39 (7) :e70530.|Genes Dis. 2023 Sep 2;11 (6) :101074.|Invest Ophthalmol Vis Sci. 2024 Jun 3;65 (6) :13.|J Exp Med. 2021 Feb 1;218 (2) :e20200887.|University of California San Diego. 2023|ACS Infect Dis. 2022 Mar 11;8 (3) :463-471.|Adv Sci (Weinh) . 2025 Apr;12 (14) :e2417686.|Am J Cancer Res. 2023 May 15;13 (5) :2055-2065.|bioRxiv. 2025 Feb 27:2025.02.21.639458.|bioRxiv. 2025 Jul 18:2025.07.14.664814.|bioRxiv. 2025 Nov 18.|Cancer Lett. 2022 Oct 28:547:215885.|Cancer Lett. 2024 Jun 21:217081.|Cell Death Dis. 2022 Jul 28;13 (7) :653.|Cell Immunol. 2021 Aug:366:104384.|EMBO J. 2025 Jan;44 (1) :141-165.|Exp Hematol Oncol. 2024 Aug 5;13 (1) :77.|Front Immunol. 2020 Jul 8:11:1430.|Front Pharmacol. 2023 Apr 4:14:1160445.|J Bone Miner Res. 2024 Jun 14:zjae093.|J Ethnopharmacol. 2024 Aug 17:118661.|J Invest Dermatol. 2022 Apr;142 (4) :1158-1170.e8.|Mol Cell. 2023 May 4;83 (9) :1502-1518.e10.|Nat Nanotechnol. 2021 Nov;16 (11) :1260-1270.|OncoImmunology. 2022 Feb 1;11 (1) :2030021.|PLoS One. 2021 Oct 27;16 (10) :e0258989.|Proc Natl Acad Sci U S A. 2023 Jan 31;120 (5) :e2213777120.|Protein Cell. 2022 Apr;13 (4) :281-301.|Sci China Life Sci. 2024 Dec;67 (12) :2664-2677.|Sci Rep. 2022 Oct 24;12 (1) :17827.|Thorac Cancer. 2022 May; 13 (9) : 1361–1368.|World J Tradit Chin Med. 2025 April 17.|World J Tradit Chin Med. 2025 Oct 28.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

STING Rabbit Polyclonal Antibody
APRab03627-01 20 µL

STING Rabbit Polyclonal Antibody

Ask
View Details
STING Rabbit Polyclonal Antibody
APRab03627-02 50 µL

STING Rabbit Polyclonal Antibody

Ask
View Details
STING Rabbit Polyclonal Antibody
APRab03627-03 100 µL

STING Rabbit Polyclonal Antibody

Ask
View Details
STING Rabbit Polyclonal Antibody
APRab03627-04 200 µL

STING Rabbit Polyclonal Antibody

Ask
View Details
Phospho-c Myb Rabbit Monoclonal Antibody
E56G4038 100 µL

Phospho-c Myb Rabbit Monoclonal Antibody

Ask
View Details
6-Chloro-L-tryptophan
MBS3847482-01 50 mg

6-Chloro-L-tryptophan

Ask
View Details